Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
MicroStrategy
MSTR
US Stock MarketDetailed Quotes
ORKA Oruka Therapeutics
- 20.310
- -0.450-2.17%
Close Dec 20 16:00 ET
- 20.310
- 0.0000.00%
Post 16:03 ET
710.82MMarket Cap-53.45P/E (TTM)
21.580High19.840Low2.54MVolume20.310Open20.760Pre Close51.87MTurnover10.86%Turnover RatioLossP/E (Static)35.00MShares33.00052wk High2.09P/B475.37MFloat Cap10.06852wk Low--Dividend TTM23.41MShs Float40838092.445Historical High--Div YieldTTM8.38%Amplitude10.068Historical Low20.402Avg Price1Lot Size
Oruka Therapeutics News
Oruka Therapeutics's ORKA-001: Promising Psoriasis Treatment Drives Buy Rating With 12-Month Price Target of $45
HC Wainwright & Co. Reiterates Buy on Oruka Therapeutics, Maintains $45 Price Target
Express News | Oruka Therapeutics Inc - Enters License Agreement With Paragon for Worldwide Rights to Orka-001
Express News | Oruka Therapeutics: On Track to Initiate Proof-of-Concept Study in Psoriasis H2 2025, Initial Efficacy Data Expected in H2 2026
Express News | Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of Orka-001, Its Novel Half-Life Extended Anti-Il-23P19 Antibody
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, Its Novel Half-life Extended Anti-IL-23p19 Antibody
Express News | Oruka Therapeutics Inc - Addition to Nbi Effective December 23, 2024
Express News | Oruka Therapeutics to Be Added to the Nasdaq Biotechnology Index (Nbi)
Oruka Therapeutics to Be Added to the Nasdaq Biotechnology Index (NBI)
A Great Week for Institutional Investors Who Own 54% of Oruka Therapeutics, Inc. (NASDAQ:ORKA)
Oruka Therapeutics (ORKA) Gets a Buy From TD Cowen
Promising Potential of Oruka Therapeutics' ORKA-001 in Psoriasis Treatment
Oruka Therapeutics: Strong Q3 and Strategic Advances
Top Premarket Gainers
H.C. Wainwright Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $45
Oruka Therapeutics Price Target Maintained With a $45.00/Share by HC Wainwright & Co.
Oruka Therapeutics Analyst Ratings
Jefferies Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $40
Oruka Therapeutics' Promising Long-Term Strategy and Advancements in Psoriasis Treatments Drive Buy Rating
Oruka Therapeutics to Present at Piper Sandler's 36th Annual Healthcare Conference
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.